JP Benya has over 30 years of operational and commercial experience in the healthcare industry, having spent 15 years in big pharma and the balance of the time with biotech and consulting startups. JP was most recently VP Commercial Development at Assembly Biosciences where he developed and implemented the commercial framework for HBV cure and microbiome-based therapeutics. JP also founded pharmaMARK LLC, a boutique consulting firm offering customer-focused strategy analyses. At Sanofi JP was responsible for the marketing of AMBIEN and AMBIEN CR. JP began his career at Schering-Plough working on INTRON A and GM-CSF.
JP is a graduate of Brown University and holds an MBA from Columbia University.